Moderna and Merck's Cancer Vaccine Shows Promise Amid Skepticism

In March 2023, Moderna's CEO, Stéphane Bancel, posed a revealing question to over 100 executives: who believed in the success of their experimental cancer vaccine? A telling silence followed, with both Bancel and President Stephen Hoge ultimately sitting down, acknowledging their own doubts.

This skepticism persisted until last week when a study involving 1,137 participants indicated that the vaccine significantly improves the chances against melanoma recurrence. Despite this promising data, some experts urge caution, suggesting that further analysis is necessary.

Source: www.statnews.com